Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor

Size: px
Start display at page:

Download "Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor"

Transcription

1 Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor Scott G. Hubosky, MD The Demetrius H. Bagley Jr., MD Associate Professor of Urology Director of Endourology Vice Chair of Quality and Safety Thomas Jefferson University Hospital Philadelphia, PA, USA

2 DISCLOSURES I HAVE NO FINANCIAL INTERESTS OR RELATIONSHIPS TO DISCLOSE

3 MULTIPLE FILLING DEFECTS AND GROSS HEMATURIA!

4 Ureteral Filling Defect with Gross Hematuria and Flank Pain!!!

5 FIBROEPITHELIAL POLYPS

6 FIBROEPITHELIAL POLYPS

7 Benign Pathology Found after Laparoscopic Radical NU 7/244 (2.9%) found to have Benign Pathology (Presumed UTUC) 5 did not have URS evaluation 2 incomplete URS evaluation (unable to access pathology) 5 with Ureteral Lesions CT Finding Polypoid ureteritis / ureteral stone PeriUreteral Wall Thickening Urothelial hyperplasia / ureteral stone Enhancing Ureteral Soft Tissue Mass Inflammatory Pseudotumor 1.5 cm Enhancing Mass in Mid Ureter Submucosal Hemorrhage Enhancing Mass Distal Ureter TB Multifocal Ureteral Wall Thickening 2 with Renal Pelvic Lesions Inflammatory Pseudotumor 4cm Enhancing UTUC renal pelvis Fibroepithelial Polyp 1.6 cm Enhancing mass renal pelvis Hong et al 2014 JSLS (18) 1-17

8

9 Potretzke et al 2016 Urology (88) 43-8

10 What is the best treatment choice?

11 Reasons NOT to do Ureteroscopy in UTUC Increased Pyelovenous Backflow = Local Tumor Spread or Promotion of Metastatic Disease / Cancer Specific Mortality Delays time to definitive Surgery (NU) Leads to Bladder Tumor Development URS does not really add anything

12 Does Flexible Ureteroscopy Promote Local Recurrence of Upper Tract Urothelial Carcinoma?? Migration of malignant cells from Increased Intrarenal Pressure? Evaluated 13 patients who had URS prior to ultimate NU (all with UTUC) Surgical (NU) specimens examined for vascular/lymphatic invasion No Tumor cells seen in Vascular/Lymphatic spaces No tumor seen outside of or penetrating renal capsule Direct extension of tumor into renal parenchyma (1) Suspected prior to URS being performed Patients followed with CT (mean 34 months) Only one patient with eventual metastatic disease Kulp & Bagley 1994 J Endourol (8) 111-3

13 Impact of Diagnostic Ureteroscopy on Long-Term Survival in UTUC patients after NU Retrospective review of 48 patients in each group. Demographics statistically equivalent including preop grade Mean follow up (42-50 months) Rate of Metastatic Disease same 12% URS group 19% Control group Overall Survival same (p=0.75) 87% URS group 76% Control group Hendin et al 1999 J Urol (161) 783-5

14 What does URS do in terms of bladder tumor development in those without prior BT hx? Sankin et al Median follow-up of 5.4 years Intravesical Recurrence Rate (IRR) higher in those with URS (58% vs. 29%) No difference in Cancer Specific Survival Luo et al Mean follow-up 40.7 months IRR higher in those with URS (40.9% vs. 27.8%) No difference in Metastasis Free Survival and Cancer Specific Survival Ishikawa et al Median follow-up 44 months IRR similar: With URS 60%, Without URS 58.7% No difference in Cancer Specific Survival 1. Sankin et al 2016 Urology (94) Luo et al 2013 Ann Surg Oncol DOI /s z 3. Ishikawa et al 2010 J Urol (184) 883-7

15 MD ANDERSON: Higher Stage UTUC The treatment paradigm needed to change Surgical Series of NU from (N = 184) Group 1 N = Group 2 N = Group 3 N = No difference in DSS among 3 groups over 20 years!!! Pts with high risk features continued to do poorly Brown et al. BJUI 2006 (98)

16 REDUCTION IN ELIGIBLE PATIENTS FOR CISPLATIN-BASED CHEMO AFTER NU Multi-institutional Retrospective Review of NU patients for UTUC Mean age 70 yrs (62 76) If cutoff for cisplatin-based chemotherapy is GFR > 60 49% eligible PREOP 19% eligible POSTOP Strengthened the argument for Neoadjuvant Chemotherapy Kaag et al. Eur Urol 2010 (58) 581-7

17 Porten et al 2014 Cancer (120)

18 Porten et al 2014 Cancer (120)

19 Observations The stakes are getting higher for UTUC treatment NEOADJUVANT CHEMOTHERAPY Better Options for Nephron Sparing Therapies Endoscopic Treatments MITOGEL Local Bladder recurrences are increased modestly Post-op MMC after URS?

20

WIRELESS URETEROSCOPY IS FEASIBLE AND SAFE

WIRELESS URETEROSCOPY IS FEASIBLE AND SAFE WIRELESS URETEROSCOPY IS FEASIBLE AND SAFE Scott G. Hubosky, MD The Demetrius H. Bagley Jr., MD Associate Professor of Urology Director of Endourology Vice Chair of Quality and Safety Thomas Jefferson

More information

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer Seth P. Lerner, MD, FACS Professor, Scott Department of Urology Beth and Dave Swalm Chair in Urologic Oncology

More information

When to Integrate Surgery for Metatstatic Urothelial Cancers

When to Integrate Surgery for Metatstatic Urothelial Cancers When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male

More information

Robotic Surgery for Upper Tract Urothelial Carcinoma. Li-Ming Su, MD

Robotic Surgery for Upper Tract Urothelial Carcinoma. Li-Ming Su, MD Robotic Surgery for Upper Tract Urothelial Carcinoma Li-Ming Su, MD David A. Cofrin Professor of Urology, Associate Chairman of Clinical Affairs, Chief, Division of Robotic and Minimally Invasive Urologic

More information

Alicia K. Morgans, MD Assistant Professor of Medicine Division of Hematology/Oncology Vanderbilt University Medical Center January 24, 2015

Alicia K. Morgans, MD Assistant Professor of Medicine Division of Hematology/Oncology Vanderbilt University Medical Center January 24, 2015 Alicia K. Morgans, MD Assistant Professor of Medicine Division of Hematology/Oncology Vanderbilt University Medical Center January 24, 2015 Overview Background Perioperative chemotherapy in MIBC Neoadjuvant

More information

Upper Tract Urothelial Cancers Nephron Sparing Strategies

Upper Tract Urothelial Cancers Nephron Sparing Strategies Upper Tract Urothelial Cancers Nephron Sparing Strategies Girish Kulkarni, MD, PhD, FRCSC Urologic surgeon, Division of Urology Princess Margaret Hospital, University Health Network Assistant Professor,

More information

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,

More information

Carcinoma of the Renal Pelvis and Ureter Histopathology

Carcinoma of the Renal Pelvis and Ureter Histopathology Carcinoma of the Renal Pelvis and Ureter Histopathology Reporting Proforma (NEPHROURETERECTOMY AND URETERECTOMY) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

Controversies in the management of Non-muscle invasive bladder cancer

Controversies in the management of Non-muscle invasive bladder cancer Controversies in the management of Non-muscle invasive bladder cancer Sia Daneshmand, MD Associate Professor of Urology (Clinical Scholar) Director of Urologic Oncology Director of Clinical Research Urologic

More information

Upper Tract Tcc. Mohan Arianayagam FRACS (Urology)

Upper Tract Tcc. Mohan Arianayagam FRACS (Urology) Upper Tract Tcc Mohan Arianayagam FRACS (Urology) Epidemiology Peak incidence 75 to 79 years 2x more common in men 7% of all renal tumours 5% of all urothelial tumours Synchronous bilateral is rare ~ 1.6%

More information

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER (Text update March 2008) A. Stenzl (chairman), N.C. Cowan, M. De Santis, G. Jakse, M. Kuczyk, A.S. Merseburger, M.J. Ribal, A. Sherif, J.A. Witjes Introduction

More information

Clinical Study Ureteroscopic Laser Treatment of Upper Urinary Tract Urothelial Cell Carcinomas: Can a Tumour Free Status Be Achieved?

Clinical Study Ureteroscopic Laser Treatment of Upper Urinary Tract Urothelial Cell Carcinomas: Can a Tumour Free Status Be Achieved? Advances in Urology Volume 2013, Article ID 429585, 4 pages http://dx.doi.org/10.1155/2013/429585 Clinical Study Ureteroscopic Laser Treatment of Upper Urinary Tract Urothelial Cell Carcinomas: Can a Tumour

More information

Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy?

Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy? Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy? 80 patients LNU (n = 40) or ONU (n = 40) CSS (p = 0.2), BRFS (p = 0.86), MFS (p = 0.12) similar for the entire cohort Subgroups of pt3 UTUC

More information

CT Urography. Bladder. Stuart G. Silverman, M.D.

CT Urography. Bladder. Stuart G. Silverman, M.D. CT Urography Stuart G. Silverman, M.D. Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Bladder Boston, MA CT Urography Stuart G.

More information

Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Andrew J. Stephenson, MD, FRCSC, FACS Director, Urologic Oncology Associate Professor of Surgery Glickman Urological and Kidney

More information

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. Male genital tract tumors Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital. adenocarcinoma Prostate Cancer most common male cancer in western countries more detected in

More information

Upper Tract Urothelial Carcinomas (UTUCs)

Upper Tract Urothelial Carcinomas (UTUCs) Upper Tract Urothelial Carcinomas (UTUCs) Part II: UTUC Treatment Options November 14, 2017 Moderated by: Presented by: Gary D. Steinberg, MD University of Chicago Medical Center Ahmad Shabsigh, MD Ohio

More information

Upper Urinary Tract Urothelial Carcinoma

Upper Urinary Tract Urothelial Carcinoma Upper Urinary Tract Urothelial Carcinoma Michael Grasso III Demetrius H. Bagley Editors Upper Urinary Tract Urothelial Carcinoma Editors Michael Grasso III Lenox Hill Hospital Department of Urology New

More information

Urothelial Tumors of the Upper Tract: Diagnosis and Management. Daniel Rapoport April 11, 2007 Urology Grand Rounds

Urothelial Tumors of the Upper Tract: Diagnosis and Management. Daniel Rapoport April 11, 2007 Urology Grand Rounds Urothelial Tumors of the Upper Tract: Diagnosis and Management Daniel Rapoport April 11, 2007 Urology Grand Rounds 1 Overview Background Epidemiology and risk factors Natural history and prognostic factors

More information

Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer

Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer Int Urol Nephrol (2014) 46:921 926 DOI 10.1007/s11255-013-0514-z UROLOGY - ORIGINAL PAPER Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series Collecting Cancer Data Bladder & Renal Pelvis NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Bladder Cancer in Primary Care. Dr Penny Kehagioglou Consultant Clinical Oncologist

Bladder Cancer in Primary Care. Dr Penny Kehagioglou Consultant Clinical Oncologist Bladder Cancer in Primary Care Dr Penny Kehagioglou Consultant Clinical Oncologist Objectives Patient presentation in primary care Investigating bladder cancer Management of bladder cancer Differential

More information

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction

More information

The Association Between The Prognosis Of Ureteral Cancer And Natural Constriction By The Common Iliac Arteriovenous Crossing

The Association Between The Prognosis Of Ureteral Cancer And Natural Constriction By The Common Iliac Arteriovenous Crossing ISPUB.COM The Internet Journal of Urology Volume 15 Number 1 The Association Between The Prognosis Of Ureteral Cancer And Natural Constriction By The Common Iliac Arteriovenous Crossing K Takahara, S Tobu,

More information

Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav Who are Candidates for Laparoscopic or Open Radical Nephrectomy Arieh Shalhav Fritz Duda Chair of Urologic Surgery Professor of Surgery and the Comprehensive Cancer Research Center Who are Candidates for

More information

The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma

The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma Ivyspring International Publisher Research Paper 686 Journal of Cancer 2013; 4(8): 686-690. doi: 10.7150/jca.7326 The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell

More information

LOWER POLE STONE DR.NOOR ASHANI MD YUSOFF DEPT. OF UROLOGY HOSP.KUALA LUMPUR

LOWER POLE STONE DR.NOOR ASHANI MD YUSOFF DEPT. OF UROLOGY HOSP.KUALA LUMPUR DR.NOOR ASHANI MD YUSOFF DEPT. OF UROLOGY HOSP.KUALA LUMPUR ! The appropriate treatment of lower pole calculi is controversial:! Shock wave lithotripsy! Retrograde ureteroscopy! Percutaneous lithotripsy

More information

The Rationale for Immunotherapy as an Adjuvant Treatment for Locally Advanced BC

The Rationale for Immunotherapy as an Adjuvant Treatment for Locally Advanced BC The Rationale for Immunotherapy as an Adjuvant Treatment for Locally Advanced BC Seth P. Lerner, MD, FACS Professor, Scott Department of Urology Beth and Dave Swalm Chair in Urologic Oncology Baylor College

More information

Non-Muscle Invasive Bladder Cancer BCG Failures: University of Iowa Hospitals and Clinics Experience. Paul Gellhaus Assistant Clinical Professor

Non-Muscle Invasive Bladder Cancer BCG Failures: University of Iowa Hospitals and Clinics Experience. Paul Gellhaus Assistant Clinical Professor Non-Muscle Invasive Bladder Cancer BCG Failures: University of Iowa Hospitals and Clinics Experience Paul Gellhaus Assistant Clinical Professor Iowa??? none Disclosures Caveats Dr. Michael O Donnell

More information

Lee et al. World Journal of Surgical Oncology (2018) 16:135

Lee et al. World Journal of Surgical Oncology (2018) 16:135 Lee et al. World Journal of Surgical Oncology (2018) 16:135 https://doi.org/10.1186/s12957-018-1411-9 RESEARCH The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial

More information

Ureteral Stenting after Flexible Ureterorenoscopy with Ureteral Access Sheath; Is It Really Needed?: A Prospective Randomized Study

Ureteral Stenting after Flexible Ureterorenoscopy with Ureteral Access Sheath; Is It Really Needed?: A Prospective Randomized Study Ureteral Stenting after Flexible Ureterorenoscopy with Ureteral Access Sheath; Is It Really Needed?: A Prospective Randomized Study J Med Assoc Thai 2017; 100 (Suppl. 3): S174-S178 Full text. e-journal:

More information

Azik Hoffman *, Ofer Yossepowitch, Yaron Erlich, Ronen Holland and David Lifshitz

Azik Hoffman *, Ofer Yossepowitch, Yaron Erlich, Ronen Holland and David Lifshitz Hoffman et al. BMC Urology 2014, 14:97 RESEARCH ARTICLE Open Access Oncologic results of Nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy

More information

ENDOSCOPIC URETERECTOMY DURING NEPHROURETERECTOMY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA

ENDOSCOPIC URETERECTOMY DURING NEPHROURETERECTOMY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA ENDOSCOPIC URETERECTOMY DURING NEPHROURETERECTOMY FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA Il. Saltirov, Ts. Petkov, G. Georgiev, K.Petkova Department of Urology and Nephrology, Military Medical

More information

Should we say farewell to ESWL?

Should we say farewell to ESWL? Should we say farewell to ESWL? HARRY WINKLER Director, section of Endo-urology Kidney stone center Dept. of Urology Sheba medical center Financial and Other Disclosures Off-label use of drugs, devices,

More information

Non Muscle Invasive Bladder Cancer. Primary and Recurrent TCC 4/10/2010. Two major consequences: Strategies: High-Risk NMI TCC

Non Muscle Invasive Bladder Cancer. Primary and Recurrent TCC 4/10/2010. Two major consequences: Strategies: High-Risk NMI TCC Intravesical Therapy 2010-When, with What, When to Stop Friday, April 9, 2010 Ralph de VereWhite, MD Director, UC Davis Cancer Center Associate Dean for Cancer Programs Professor, Department of Urolgoy

More information

Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy

Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy 530 Preoperative risk factors for extraurothelial recurrence in N0M0 patients with renal pelvic cancer treated by radical nephroureterectomy KEIICHI ITO, JUNICHI ASAKUMA, KENJI KURODA, KAZUYOSHI TACHI,

More information

Urothelial carcinomas of the upper urinary tract how does UK practice compare with European guidelines: is there a difference?

Urothelial carcinomas of the upper urinary tract how does UK practice compare with European guidelines: is there a difference? 699543URO0010.1177/2051415817699543Journal of Clinical UrologyMoon et al. research-article2018 EAU Guidelines Urothelial carcinomas of the upper urinary tract how does UK practice compare with European

More information

Old and New Radiation for Bladder and Upper Tract Cancers. Bridget Koontz Radiation Oncology Duke Cancer Institute

Old and New Radiation for Bladder and Upper Tract Cancers. Bridget Koontz Radiation Oncology Duke Cancer Institute Old and New Radiation for Bladder and Upper Tract Cancers Bridget Koontz Radiation Oncology Duke Cancer Institute Disclosures Janssen funded clinical research BlueEarth Diagnostics advisory board member

More information

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT) Bladder Case 1 February 17, 2007 Specimen (s) received: Bladder Tumor Pre-operative Diagnosis: Bladder Cancer Post operative Diagnosis: Bladder Cancer Procedure: Cystoscopy, transurethral resection of

More information

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in

More information

ELECTIVE PARTIAL NEPHRECTOMY FOR T1B RCC. Vitaly Margulis MD. Associate Professor of Urology

ELECTIVE PARTIAL NEPHRECTOMY FOR T1B RCC. Vitaly Margulis MD. Associate Professor of Urology ELECTIVE PARTIAL NEPHRECTOMY FOR T1B RCC Vitaly Margulis MD Associate Professor of Urology NEPHRON SPARING SURGERY WHY? MAXIMIZING NEPHRON MASS SAVES LIVES ELECTIVE PARTIAL NEPHRECTOMY IF: TECHNICALLY

More information

Bladder Sparing Treatment of Muscle Invasive Bladder Cancer

Bladder Sparing Treatment of Muscle Invasive Bladder Cancer Bladder Sparing Treatment of Muscle Invasive Bladder Cancer Pr Alexandre de la Taille CHU Mondor, Créteil INSERMU955Eq07 adelataille@hotmail.com High-Risk Invasive and Muscle-Invasive BCa Radical cystectomy

More information

Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes

Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes ORIGINAL Article Vol. 39 (6): 817-822, November - December, 2013 doi: 10.1590/S1677-5538.IBJU.2013.06.07 Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic

More information

Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic

Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns Seth P. Lerner, MD, FACS Professor of Urology Beth and Dave Swalm Chair in Urologic Oncology Scott Department of Urology Baylor College of

More information

BLADDER CANCER: PATIENT INFORMATION

BLADDER CANCER: PATIENT INFORMATION BLADDER CANCER: PATIENT INFORMATION The bladder is the balloon like organ located in the pelvis that stores and empties urine. Urine is produced by the kidneys, is conducted to the bladder by the ureters,

More information

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic Surgery Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic technique was introduced in urologic surgery in the 1990s Benefits: Improved recovery time, decreased morbidity Matthew

More information

Carcinoma of the Urinary Bladder Histopathology

Carcinoma of the Urinary Bladder Histopathology Carcinoma of the Urinary Bladder Histopathology Reporting Proforma (Radical & Partial Cystectomy, Cystoprostatectomy) Includes the International Collaboration on Cancer reporting dataset denoted by * Family

More information

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management Nicholas G. Cost, M.D. Assistant Professor, Department of Surgery, Division of Urology University of Colorado Cancer Center Fifteenth

More information

Suspected Renal Colic in the Emergency Department

Suspected Renal Colic in the Emergency Department Suspected Renal Colic in the Emergency Department Who Needs Urologic Intervention? Yan JW, McLeod SL, Edmonds ML, Sedran RJ, Theakston KD CAEP June 4, 2012 Disclosure No conflicts of interest to declare

More information

Collection of Recorded Radiotherapy Seminars

Collection of Recorded Radiotherapy Seminars IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology

More information

Staging and Grading Last Updated Friday, 14 November 2008

Staging and Grading Last Updated Friday, 14 November 2008 Staging and Grading Last Updated Friday, 14 November 2008 There is a staging graph below Blood in the urine is the most common indication that something is wrong. Often one will experience pain or difficulty

More information

BJUI. Secondary bladder cancer after upper tract urothelial carcinoma in the US population

BJUI. Secondary bladder cancer after upper tract urothelial carcinoma in the US population BJUI Secondary bladder cancer after upper tract urothelial carcinoma in the US population Max Kates, Gina M. Badalato, Mantu Gupta and James M. McKiernan Department of Urology, Columbia University College

More information

Title high grade malignancy: report of a. Takeuchi, Hideo; Konami, Teruo; Tak Tomoyoshi, Tadao; Yoshitomi, Joji

Title high grade malignancy: report of a. Takeuchi, Hideo; Konami, Teruo; Tak Tomoyoshi, Tadao; Yoshitomi, Joji Title Lobulated polypoid tumor of the ure high grade malignancy: report of a Author(s) Takeuchi, Hideo; Konami, Teruo; Tak Tomoyoshi, Tadao; Yoshitomi, Joji Citation 泌尿器科紀要 (1989), 35(8): 1401-1404 Issue

More information

3.1 Investigations for Patients Presenting with Haematuria Table 1

3.1 Investigations for Patients Presenting with Haematuria Table 1 3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements

More information

September 10, Dear Dr. Clark,

September 10, Dear Dr. Clark, September 10, 2015 Peter E. Clark, MD Chair, NCCN Bladder Cancer Guidelines (Version 2.2015) Associate Professor of Urologic Surgery Vanderbilt Ingram Cancer Center Nashville, TN 37232 Dear Dr. Clark,

More information

Cystitis cystica is a rare chronic reactive inflammatory

Cystitis cystica is a rare chronic reactive inflammatory JOURNAL OF ENDOUROLOGY CASE REPORTS Volume 3.1, 2017 Mary Ann Liebert, Inc. Pp. 34 38 DOI: 10.1089/cren.2017.0010 Case Report Cystitis Cystica as a Large Solitary Bladder Cyst Stephanie Potts, MBChB and

More information

Highlighting Clinical Trials Muscle Invasive Bladder Cancer

Highlighting Clinical Trials Muscle Invasive Bladder Cancer Highlighting Clinical Trials Muscle Invasive Bladder Cancer Part I: The Basics of MIBC Clinical Trials June 19, 2018 Presented by: Dr. Peter Black is a urologic oncologist at Vancouver General Hospital,

More information

What is the role of partial nephrectomy in the context of active surveillance and renal ablation?

What is the role of partial nephrectomy in the context of active surveillance and renal ablation? What is the role of partial nephrectomy in the context of active surveillance and renal ablation? Dogu Teber Department of Urology University Hospital Heidelberg Coming from Heidelberg obligates to speak

More information

Citation International journal of urology (2. Right which has been published in final f

Citation International journal of urology (2.  Right which has been published in final f Title Novel constant-pressure irrigation of renal pelvic tumors after ipsila Nakamura, Kenji; Terada, Naoki; Sug Author(s) Toshinori; Matsui, Yoshiyuki; Imamu Kazutoshi; Kamba, Tomomi; Yoshimura Citation

More information

L. Alexandre Frigini MD; Aaron Thomas, MD; Veronica Lenge de Rosen, MD

L. Alexandre Frigini MD; Aaron Thomas, MD; Veronica Lenge de Rosen, MD Computed Tomography Urography (CTU) for Evaluation of Asymptomatic microscopic hematuria. Is intravenous contrast administration warranted for all patients? A retrospective evaluation utilizing ACR s Appropriateness

More information

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Kidney Case 1 SURGICAL PATHOLOGY REPORT Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which

More information

URETERORENOSCOPY: INDICATIONS AND COMPLICATIONS - A RETROSPECTIVE STUDY

URETERORENOSCOPY: INDICATIONS AND COMPLICATIONS - A RETROSPECTIVE STUDY Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 9 (58) No. 2-2016 URETERORENOSCOPY: INDICATIONS AND COMPLICATIONS - A RETROSPECTIVE STUDY L. MAXIM 1,2 I.A. BĂNUŢĂ 2 I.

More information

Chemotherapy and Bladder Cancer. Blayne Welk UBC Urology Grand Rounds June 4, 2008

Chemotherapy and Bladder Cancer. Blayne Welk UBC Urology Grand Rounds June 4, 2008 Chemotherapy and Bladder Cancer Blayne Welk UBC Urology Grand Rounds June 4, 2008 Outline Review of Incidence and Impact of bladder cancer Neoadjuvant chemotherapy Adjuvant chemotherapy Bladder preservation

More information

BJUI. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience

BJUI. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience BJUI Long-term endoscopic management of upper tract urothelial carcinoma: 2-year single-centre experience Mark L. Cutress, Grant D. Stewart *, Simon Wells-Cole, Simon Phipps, Ben G. Thomas and David A.

More information

The Minimally Invasive Management of Ureteropelvic Junction Obstruction in Horseshoe Kidneys

The Minimally Invasive Management of Ureteropelvic Junction Obstruction in Horseshoe Kidneys Thomas Jefferson University Jefferson Digital Commons Department of Urology Faculty Papers Department of Urology 1-25-2011 The Minimally Invasive Management of Ureteropelvic Junction Obstruction in Horseshoe

More information

Structured Follow-Up after Colorectal Cancer Resection: Overrated. R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007

Structured Follow-Up after Colorectal Cancer Resection: Overrated. R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007 Structured Follow-Up after Colorectal Cancer Resection: Overrated R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007 Guidelines for Colonoscopy Production: Surveillance US Multi-Society

More information

Ureteroscopic Management of Patients with Upper Tract Transitional Cell Carcinoma

Ureteroscopic Management of Patients with Upper Tract Transitional Cell Carcinoma european urology supplements 6 (2007) 560 567 available at www.sciencedirect.com journal homepage: www.europeanurology.com Ureteroscopic Management of Patients with Upper Tract Transitional Cell Carcinoma

More information

Majid Eshghi, MD, FACS, MBA Valhalla, New York January 2018

Majid Eshghi, MD, FACS, MBA Valhalla, New York January 2018 Epilogue During the trailblazing years of endourology in the early 1980s, any unusual or challenging case provided an opportunity to envision, develop, and try new approaches within this field. Between

More information

Atypical Carcinoid Neuroendocrine Tumor of the Ureter: A Case Report and Literature Review

Atypical Carcinoid Neuroendocrine Tumor of the Ureter: A Case Report and Literature Review THIEME Case Report e171 Atypical Carcinoid Neuroendocrine Tumor of the Ureter: A Case Report and Literature Review Huay Shan Yuen, MBchB, MRCS 1 Gerald Henner Rix, MA, FRCS 1 Soumadri Sen, MBBS, FRCP 2

More information

Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney

Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney Case Study TheScientificWorldJOURNAL (2004) 4, 965 968 ISSN 1537-744X; DOI 10.1100/tsw.2004.196 Renal Pelvis Squamous Cell Carcinoma and Renal Cell Carcinoma in a Tuberculous Kidney M. Al-Assiri 1, M.F.

More information

EAU Guidelines recommendations on upper tract urothelial carcinoma. Oliver Hakenberg Department of Urology Rostock University Germany

EAU Guidelines recommendations on upper tract urothelial carcinoma. Oliver Hakenberg Department of Urology Rostock University Germany EAU Guidelines recommendations on upper tract urothelial carcinoma Oliver Hakenberg Department of Urology Rostock University Germany Urothelial carcinoma 6% 2% 90% 2% Evidence-based guidelines Upper tract

More information

ASYMPTOMATIC MICROSCOPIC HEMATURIA IN WOMEN JOLYN HILL, MD ASSISTANT PROFESSOR, CLINICAL UROGYNECOLOGY FEBRUARY14, 2017

ASYMPTOMATIC MICROSCOPIC HEMATURIA IN WOMEN JOLYN HILL, MD ASSISTANT PROFESSOR, CLINICAL UROGYNECOLOGY FEBRUARY14, 2017 ASYMPTOMATIC MICROSCOPIC HEMATURIA IN WOMEN JOLYN HILL, MD ASSISTANT PROFESSOR, CLINICAL UROGYNECOLOGY FEBRUARY14, 2017 DISCLOSURES No financial disclosures Urogynecologist via Ob/Gyn pathway ASYMPTOMATIC

More information

Transitional Cell Carcinoma of the Upper Ureter Metastatic to the Thoracic Spine Presenting as a Spinal Cord Compression

Transitional Cell Carcinoma of the Upper Ureter Metastatic to the Thoracic Spine Presenting as a Spinal Cord Compression Case Study TheScientificWorldJOURNAL (2008) 8, 223 227 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2008.43 Transitional Cell Carcinoma of the Upper Ureter Metastatic to the Thoracic Spine Presenting as

More information

ROBOTIC VS OPEN RADICAL CYSTECTOMY

ROBOTIC VS OPEN RADICAL CYSTECTOMY ROBOTIC VS OPEN RADICAL CYSTECTOMY A REVIEW Colin Lundeen December 14, 2016 Objectives Review the history of radical cystectomy Critically analyze recent RCTs comparing open radical cystectomy (ORC) to

More information

Trimodality Therapy for Muscle Invasive Bladder Cancer

Trimodality Therapy for Muscle Invasive Bladder Cancer Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,

More information

Cytoreductive Radical Prostatectomy for de Novo Metastatic Prostate Cancer

Cytoreductive Radical Prostatectomy for de Novo Metastatic Prostate Cancer Cytoreductive Radical Prostatectomy for de Novo Metastatic Prostate Cancer Timothy G. Wilson, MD Professor and Chair of Urology John Wayne Cancer Institute Santa Monica, California Disclosures I am on

More information

PROGRESS IN ENDOSCOPIC. Olivier Traxer.

PROGRESS IN ENDOSCOPIC. Olivier Traxer. PROGRESS IN ENDOSCOPIC TREATMENT OF UROLITHIASIS Olivier Traxer Tenon Hospital, Paris, France Université Pierre & Marie CURIE (PARIS VI) Université Pierre & Marie CURIE (PARIS VI) olivier.traxer@tnn.aphp.fr

More information

Index. B Balkan endemic nephropathy (BEN), BEN. See Balkan endemic nephropathy (BEN)

Index. B Balkan endemic nephropathy (BEN), BEN. See Balkan endemic nephropathy (BEN) A AA. See Aristolochic acid (AA) ADC. See Apparent diffusion coefficient (ADC) Adjuvant chemotherapy bladder cancer, 183 cancer specific survival (CSS), 184 cisplatin, 183 184 disease free survival (DFS),

More information

Organ-sparing treatment of invasive transitional cell bladder carcinoma

Organ-sparing treatment of invasive transitional cell bladder carcinoma Journal of BUON 7: 241-245, 2002 2002 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Organ-sparing treatment of invasive transitional cell bladder carcinoma C. Damyanov, B. Tsingilev,

More information

ISSN East Cent. Afr. J. surg. (Online)

ISSN East Cent. Afr. J. surg. (Online) 87 Ureteroscopy in a Resource Limited Setting: The Tikur Anbessa General Specialized Hospital Experience in Addis Ababa, Ethiopia. D. Andualem, L. Be-ede, T. Mulat, L. Samodi Addis Ababa University-School

More information

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER 10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg

More information

Primary Squamous Cell Carcinoma Of Kidney - A Case Report And Review Of Literature.

Primary Squamous Cell Carcinoma Of Kidney - A Case Report And Review Of Literature. ISPUB.COM The Internet Journal of Nephrology Volume 6 Number 1 Primary Squamous Cell Carcinoma Of Kidney - A Case Report And Review Of Literature. P Kaur, A Chauhan, G Singh, S Kataria, R Kalra Citation

More information

Appendix 4 Urology Care Pathways

Appendix 4 Urology Care Pathways Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable

More information

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery. Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This

More information

Alpha blockers have no role in renal colic

Alpha blockers have no role in renal colic Alpha blockers have no role in renal colic HARRY WINKLER Director, section of Endourology Kidney stone center Dept.of Urology Sheba Medical Center Financial and Other Disclosures Off-label use of drugs,

More information

Endoscopic Removal of a Long Fibroepithelial Polyp of the Ureter in an Adolescent *

Endoscopic Removal of a Long Fibroepithelial Polyp of the Ureter in an Adolescent * Open Journal of Clinical & Medical Abstract Case Reports Volume 2 (2016) Issue 12 ISSN 2379-1039 Endoscopic Removal of a Long Fibroepithelial Polyp of the Ureter in an Adolescent * Case M. Wood, MD; Andrew

More information

CHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre

CHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre CHEMO-RADIOTHERAPY FOR BLADDER CANCER Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre AIMS Muscle invasive disease Current Gold-Standard Rationale behind Chemo-Radiotherapy

More information

Upper urinary tract urothelial carcinoma (UTUC)

Upper urinary tract urothelial carcinoma (UTUC) JOURNAL OF ENDOUROLOGY Volume 29, Number 8, August 2015 ª Mary Ann Liebert, Inc. Pp. --- --- DOI: 10.1089/end.2015.0044 Original Research Immediate Nephroureterectomy or After Attempting Conservative Treatment,

More information

The merits of cytology in the workup for upper tract urothelial carcinoma - a contemporary review of a perplexing issue

The merits of cytology in the workup for upper tract urothelial carcinoma - a contemporary review of a perplexing issue ORIGINAL ARTICLE Vol. 40 (4): 493-498, July. August, 2014 doi: 10.1590/S1677-5538.IBJU.2014.04.07 The merits of cytology in the workup for upper tract urothelial carcinoma - a contemporary review of a

More information

T1HG Bladder Cancer What is the Best Therapy?

T1HG Bladder Cancer What is the Best Therapy? T1HG Bladder Cancer What is the Best Therapy? Ashish M. Kamat, MD, MBBS, FACS Professor of Urology Director, Urologic Oncology Fellowship Guidelines for T1HG Bladder Cancer AUA Recommendation: BCG induction

More information

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys? Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation Ronald J. Zagoria, M.D. UCSF Professor and Vice Chair Abdominal Imaging Section Chief Basics Where are your kidneys? What is ablation? Facts

More information

Correspondence should be addressed to Xuesong Li; and Liqun Zhou;

Correspondence should be addressed to Xuesong Li; and Liqun Zhou; BioMed Research International, Article ID 529186, 10 pages http://dx.doi.org/10.1155/2014/529186 Clinical Study Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial

More information

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation. Prostate t Cancer MR Report Disclosure Information Vikas Kundra, M.D, Ph.D. I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a g product

More information

A Personal History NIH CWRU U of TN U of Miami Animal Model for Bladder Cancer Carcinogen induced FANFT Three Models Primary tumors individual tumors, simulates clinical scenario of locally advanced cancer

More information

Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients

Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients Turk J Urol 2018; 44(3): 213-20 DOI: 10.5152/tud.2018.19677 UROONCOLOGY Original Article 213 Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma:

More information

Radical Cystectomy Often Too Late? Yes, But...

Radical Cystectomy Often Too Late? Yes, But... european urology 50 (2006) 1129 1138 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Radical Cystectomy Often Too Late? Yes, But... Urs E. Studer

More information

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy Urological Oncology Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy Evanguelos Xylinas 1,5, Michael Rink 1,7, Vitaly Margulis

More information

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules Multiple Primary and Histology Site Specific Coding Rules URINARY 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways to view the Multiple l Primary/Histology

More information